XML 55 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation  
Schedule of weighted-average assumptions used in determining fair value of share based awards

Year ended

    

    

    

 

December 31, 

2024

2023

2022

 

Assumptions

 

  

 

  

 

  

Dividend yield

 

0

%  

0

%

0

%

Risk free interest rate

 

4.24%-4.29

%  

3.69%-4.89

%

1.84%-4.27

%

Expected volatility

 

77.69%-80.62

%  

71.73%-94

%

91%-94

%

Expected lives

 

1.5 years

 

1.5-2.0 years

 

1.5-2.75 years

Schedule of the activity for stock options issued

    

    

Weighted

Average

Stock Options and Stock Appreciation Rights

Shares

Exercise Price

Outstanding at December 31, 2021

 

2,604,023

$

1.03

-Cancelled

 

(11,781)

$

3.75

-Exercised

 

(583,273)

$

1.15

 -Granted (1)

 

381,181

$

4.33

Outstanding at December 31, 2022

 

2,390,150

$

1.51

-Cancelled

 

(48,268)

$

5.67

-Exercised

 

(296,973)

$

2.68

 -Granted (2)

 

602,526

$

10.02

Outstanding at December 31, 2023

2,647,435

$

3.31

-Cancelled

(10,176)

$

4.54

-Exercised

(39,402)

$

7.24

 -Granted (3)

133,371

$

10.85

Outstanding at December 31, 2024

 

2,731,228

$

3.63

(1)Options to purchase 381,181 shares were granted in 2022, of which options to purchase 40,588 shares vested immediately in 2022 and the remainder vested 50% immediately and 50% one year after the date of the grants.
(2)Options to purchase 584,826 shares were granted in 2023, of which options to purchase 337,727 shares vested immediately in 2023 and the remainder vested 50% immediately and 50% one year after the date of the grants. In addition, 17,700 stock appreciation rights were granted in January 2023 with a six- month vesting period.
(3)Options to purchase 133,371 shares were granted in 2024, of which options to purchase 111,975 shares vested immediately in 2024 and the remainder vested 50% immediately and 50% one year after the date of the grants.
Schedule of weighted average contractual life in years and the weighted average exercise price

    

    

Weighted 

    

Average

Remaining

Weighted

Number of

Contractual

Average

December 31, 2024

Options

Life (Years)

Exercise Price

Options outstanding and vested

 

2,713,522

 

3.26

$

3.55

    

    

Weighted 

    

Average

Remaining

Weighted

Number of

Contractual

Average

December 31, 2023

Options

Life(Years)

Exercise Price

Options outstanding and vested

 

2,400,336

 

4.47

$

2.60

Schedule of intrinsic value

    

2024

    

2023

    

2022

Intrinsic value of options vested

$

$

2,886,080

$

1,249,506

Intrinsic value of options exercised

$

184,282

$

2,565,056

$

4,051,422